IRONWOOD PHARMACEUTICALS, INC. Environmental Analytics
Environmental and financial analysis dashboard for IRONWOOD PHARMACEUTICALS, INC.. Industry: PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
Company Overview for IRONWOOD PHARMACEUTICALS, INC.
Highlights
Showing data for FY2022
Operational Environmental Cost
$4.55m
Operational Environmental Cost Intensity
1.11%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$2.91m
Decoupling Rate (2020-2022)
-62%
Adjusted EBITDA
$257m
Adjusted EBITDA Margin
63%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 42.13% | -1.60% | 9.60% | ||
| 0.13% | 0.18% | 0.17% | 0.18% | |
| 115.63% | 57.83% | 14.68% | ||
| 0.29% | 0.59% | 0.93% | 0.99% | |
| $2m | $3m | $5m | $5m | |
| 92.64% | 44.12% | 13.88% | ||
| 0.42% | 0.76% | 1.11% | 1.17% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
63%
Adjusted EBIT Margin
62%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$390m | $414m | $411m | $443m | |
| 6.22% | -0.76% | 7.83% | ||
$248m | $180m | $149m | $1,368m | |
| 63.57% | 43.61% | 36.33% | 308.89% | |
$142m | $233m | $261m | $-925m | |
| 36.43% | 56.39% | 63.67% | -208.89% | |
$138m | $232m | $260m | $-926m | |
| 35.51% | 56.03% | 63.33% | -209.25% | |
| ENVIRONMENTAL COST DATA | ||||
$2m | $3m | $5m | $5m | |
| 0.42% | 0.76% | 1.11% | 1.17% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$140m | $230m | $257m | $-930m | |
| 36.01% | 55.62% | 62.56% | -210.06% | |
$137m | $229m | $255m | $-932m | |
| 35.09% | 55.26% | 62.22% | -210.42% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
RESEARCH AND EXPERIMENTAL DEVELOPMENT ON NATURAL SCIENCES AND ENGINEERING
Scope 1 (% of Sales)
0.17%
Scope 2 (% of Sales)
0.93%
Operational Environmental Cost Intensity
1.11%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
IRONWOOD PHARMACEUTICALS, INC. | US | $5m | 1.11% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022